Celia Morgan

Celia is interested in the effects of drugs and alcohol on the brain and behaviour. Her research has concentrated on examining both the benefits and side effects of recreational drugs on cognition, mental health and neurobiology. Through behavioural, neuroimaging studies and clinical trials, Celia has investigated the potentially therapeutic sides of controlled substances in clinical trials aimed at the treatment of addiction and in particularly looking at drugs such as ketamine and MDMA in combination with psychological therapies. Celia completed her undergraduate degree and Ph.D at UCL, along with faculty posts but was and was given a Chair in Psychopharmacology in 2015.

Celia is leading a number of clinical trials looking at the use of classic psychedelics and ketamine in the treatment of mental health disorders.